(19)
(11) EP 4 580 609 A2

(12)

(88) Date of publication A3:
16.05.2024

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23861498.6

(22) Date of filing: 29.08.2023
(51) International Patent Classification (IPC): 
A61K 9/51(2006.01)
A61K 38/45(2006.01)
C12N 9/12(2006.01)
A61K 48/00(2006.01)
A61P 11/00(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/88; A61K 47/6929; A61K 48/0025; A61K 48/0041; A61K 48/0091; A61K 47/541
(86) International application number:
PCT/US2023/073104
(87) International publication number:
WO 2024/050372 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 30.08.2022 US 202263402195 P

(71) Applicant: Rejuvenation Technologies Inc.
Mountain View, CA 94043 (US)

(72) Inventors:
  • RAMUNAS, John
    Mountain View, CA 94043 (US)
  • MARKOV, Glenn Jeremy
    Mountain View, CA 94043 (US)

(74) Representative: Maiwald GmbH 
Grünstraße 25
40212 Düsseldorf
40212 Düsseldorf (DE)

   


(54) COMPOSITIONS AND METHODS FOR DELIVERY OF RNA